2009
DOI: 10.1016/j.ejphar.2009.05.017
|View full text |Cite
|
Sign up to set email alerts
|

Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent α-glucosidase and α-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
131
0
2

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 227 publications
(142 citation statements)
references
References 32 publications
3
131
0
2
Order By: Relevance
“…In particular, 4-6 exhibited the most potent -glucosidase inhibition, this corresponding to previous work indicating phlorotannins to be potent -glucosidase inhibitors. [37][38][39]57) These results strongly suggest that the molecular size of the phlorotannins and number of hydroxyl groups present in the molecules are important for strong interaction with enzyme molecules with consequent inhibition of the enzyme. Our results are also consistent with those of a previous study.…”
Section: Discussionmentioning
confidence: 79%
“…In particular, 4-6 exhibited the most potent -glucosidase inhibition, this corresponding to previous work indicating phlorotannins to be potent -glucosidase inhibitors. [37][38][39]57) These results strongly suggest that the molecular size of the phlorotannins and number of hydroxyl groups present in the molecules are important for strong interaction with enzyme molecules with consequent inhibition of the enzyme. Our results are also consistent with those of a previous study.…”
Section: Discussionmentioning
confidence: 79%
“…Over the past several decades seaweeds have generated an enormous amount of interest in the pharmacological industry with enormous medicinal properties. They are rich in antioxidants such as alkaloids, flavonoids, pigments, carotenoids, enzymes and polysaccharides (Heo et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…It was reported that many synthetic saccharides may reduce plasma glucose via retarding the liberation of glucose from dietary complex carbohydrates in the small intestine. However, the application of these inhibitors has often been reported to induce disturbances in the gastrointestinal tract, including flatulence, diarrhea and abdominal pain (Heo et al 2009). …”
Section: Introductionmentioning
confidence: 99%
“…One of the therapeutic approaches for decreasing postprandial hyperglycemia is to retard absorption of glucose by inhibiting carbohydrate hydrolyzing enzymes such as aamylase in the digestive organs (Heo et al 2009). It was reported that many synthetic saccharides may reduce plasma glucose via retarding the liberation of glucose from dietary complex carbohydrates in the small intestine.…”
Section: Introductionmentioning
confidence: 99%